CD40 antibody
Quick Overview for CD40 antibody (ABIN1383855)
Target
See all CD40 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Recognises the Bp50 antigen, a 48 kDa protein
-
Purification
- Ion exchange chromatography
-
Immunogen
- Raji cell line,Myeloma X63/AG.8653 x Balb/c spleen cells
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
- Use 10 μL to label 10^6 cells or 100 μL of whole blood
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Phosphate-buffered saline with 1 % BSA and 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Stable at +2-8°C for 12 months. For longer storage freeze aliquots.
-
-
-
: "The complement inhibitor low molecular weight dextran sulfate prevents TLR4-induced phenotypic and functional maturation of human dendritic cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 181, Issue 2, pp. 878-90, (2008) (PubMed).
: "Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells." in: Blood, Vol. 99, Issue 8, pp. 2913-21, (2002) (PubMed).
: "Heterogeneity of antigen expression among human umbilical cord vascular endothelial cells: identification of cell subsets by co-expression of haemopoietic antigens." in: Immunology letters, Vol. 48, Issue 1, pp. 1-9, (1996) (PubMed).
-
: "The complement inhibitor low molecular weight dextran sulfate prevents TLR4-induced phenotypic and functional maturation of human dendritic cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 181, Issue 2, pp. 878-90, (2008) (PubMed).
-
- CD40
-
Alternative Name
- CD40
-
Molecular Weight
- 48 kDa
-
Pathways
- NF-kappaB Signaling, Cellular Response to Molecule of Bacterial Origin, M Phase, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Target
-